Lucid Share Price

Lucid Share Price

NASDAQ: LUCD | Micro Cap | Healthcare
$0.40
+$0.01 (1.53%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Lucid Stock Performance

Open
$0.40
Prev. Close
$0.40
Circuit Range
N/A
Day Range
$0.37 - $0.42
Year Range
$0.30 - $1.62
Volume
46,375
Average Traded
$0.40

Lucid Share Price Today

As of 19 November 2026, Lucid Diagnostics Inc.'s share price is $0.40. The stock opened at $0.40, compared to its previous close of $0.40. During today's trading session, Lucid Diagnostics Inc.'s share price traded between $0.37 and $0.42, with an average price of $0.39. Over the past 52 weeks, the stock has recorded a high of $1.62 and a low of $0.30. In terms of performance, Lucid Diagnostics Inc.'s share price has declined by 60.78% over the last six months and is down 61.89% on a year-on-year basis.

Lucid Share Price Chart

Line chart of the Lucid price trend over the selected period. The price rose overall, ranging from 0.37 to 0.42, ending at 0.40.
$0.37$0.42
L
Show Current Price
H

Lucid Stock Fundamentals & Key Indicators

Market Cap
$41.19M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.31
Revenue (TTM)
$4.71B
Return On Equity (TTM)
-1033.14%
Profit Margin
-1498.30%
Debt to Equity
2.92
Quarterly Earnings Growth YoY
58.94%

Lucid Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$1.50$1.26$1.47$1.20
Net Profit-$16.27-$23.63-$14.72-$6.68
Net Profit Margin-1084.67%-1875.40%-1001.36%-556.67%
Income ChangeN/A-45.24%37.71%54.62%

Lucid Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.38$2.43$4.35$4.71
Net Profit-$56.17-$52.67-$53.03-$70.57
Net Profit Margin-14781.58%-2167.49%-1219.08%-1498.30%
Income ChangeN/A6.23%-0.68%-33.08%

Lucid Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets2.985.575.28.15
Current Assets37.4725.1522.0724.36
Total Assets40.4530.7227.2732.51
Non Current Liabilities0.931.80.21.04
Current Liabilities28.5823.5229.388.43
Total Liabilities29.5125.3229.589.46
Shareholders' Equity10.945.39-2.3123.05

Lucid Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-46.49-44.14-32.82-29.69
Investing-0.2-0.65-0.22-4.11
Financing59.0348.2529.462.61

About Lucid

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

Lucid Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.40
$0.40
-1.48%
Oct 2026
$0.71
$0.41
-46.29%
Sep 2026
$0.97
$0.75
-23.61%
Aug 2026
$0.90
$0.99
+13.06%
Jul 2026
$1.08
$0.87
-18.03%
Jun 2026
$1.03
$1.06
+3.40%
May 2026
$1.08
$1.03
-3.74%
Apr 2026
$1.16
$1.07
-6.96%
Mar 2026
$1.41
$1.15
-20.69%
Feb 2026
$1.18
$1.45
+22.88%
Jan 2026
$1.08
$1.18
+8.76%
Dec 2025
$1.06
$1.08
+2.36%

Lucid Share Price FAQs